---
document_datetime: 2023-09-21 18:09:12
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/steglujan-epar-all-authorised-presentations_en.pdf
document_name: steglujan-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.6732514
conversion_datetime: 2025-12-20 15:51:45.07273
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/18/1266/001   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 14 tablets                 |
|--------------------|-------------|-----------------|----------------------|------------|----------------------------|----------------------------|
| EU/1/18/1266/002   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 28 tablets                 |
| EU/1/18/1266/003   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 30 tablets                 |
| EU/1/18/1266/004   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 30 x 1 tablets (unit dose) |
| EU/1/18/1266/005   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 84 tablets                 |
| EU/1/18/1266/006   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 90 tablets                 |
| EU/1/18/1266/007   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 14 tablets                 |
| EU/1/18/1266/008   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 28 tablets                 |
| EU/1/18/1266/009   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 30 tablets                 |
| EU/1/18/1266/010   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 30 x 1 tablets (unit dose) |
| EU/1/18/1266/011   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 84 tablets                 |
| EU/1/18/1266/012   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 90 tablets                 |
| EU/1/18/1266/013   | Steglujan   | 5 mg / 100 mg   | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 98 tablets                 |
| EU/1/18/1266/014   | Steglujan   | 15 mg / 100 mg  | Film-coated tablet   | Oral use   | Blister (alu/PVC/PA/alu)   | 98 tablets                 |